Floatz logo

Therapeutic Asset Ratings

205 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Axicabtagene Ciloleucel
Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Ruijin HospitalP4BBB (77)
Evomela
Childhood Diffuse Large Cell Lymphoma
Ruijin HospitalP4BBB (76)
Axicabtagene Ciloleucel
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Ruijin HospitalP4BBB (75)
ETOPOSIDE
Recurrent Mantle Cell Lymphoma
Ruijin HospitalP4BBB (75)
Calcium folinate pentahydrate
Neoplasm Metastasis
Ruijin HospitalP4BBB (74)
Eloxatin
Neoplasm Metastasis
Ruijin HospitalP4BBB (74)
FLUOROURACILUM
Neoplasm Metastasis
Ruijin HospitalP4BBB (74)
FILGRASTIM
Recurrent Adult Diffuse Large Cell Lymphoma
Ruijin HospitalP3BBB (74)
Jwcar029
Relapsed or Refractory B-cell Lymphoma
Ruijin HospitalP4BBB (72)
Rivoceranib
Newly Diagnosed Peripheral T-cell Lymphoma
Ruijin HospitalP4BBB (72)
Tucidinostat
Extranodal NK/T-cell Lymphoma
Ruijin HospitalP4BB (70)
Busulphan
Adult Acute Myeloid Leukemia in Remission
Ruijin HospitalP3BB (70)
Decitabine
Recurrent Adult Acute Myeloid Leukemia
Ruijin HospitalP3BB (70)
Tucidinostat
Peripheral T Cell Lymphoma
Ruijin HospitalP4BB (69)
(+)-VINCRISTINE
CNS Lymphoma
Ruijin HospitalP4BB (69)
Polatuzumab Vedotin
Refractory Diffuse Large B-Cell Lymphoma
Ruijin HospitalP3BB (69)
Tislelizumab
Hepatic Metastasis of Pancreatic Cancer
Ruijin HospitalP3BB (69)
S-1
Metastatic Pancreatic Cancer
Ruijin HospitalP4BB (68)
GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM
DLBCL
Ruijin HospitalP3BB (68)
Polatuzumab Vedotin
Large B-Cell Lymphoma (LBCL)
Ruijin HospitalP3BB (68)
Evomela
Diffuse Large B Cell Lymphoma
Ruijin HospitalP4BB (67)
Mitoxantrone
Myeloid Sarcoma
Ruijin HospitalP3BB (67)
Decitabine
Diffuse Large B Cell Lymphoma
Ruijin HospitalP4BB (66)
Decitabine
PTCL
Ruijin HospitalP3BB (66)
PEGASPARGASE
Lymphoma
Ruijin HospitalP3BB (66)
Showing 1 to 25 of 205 assets
PreviousPage 1 of 9Next